---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-115534"
form_type: "8-K"
ticker: "IMNM"
cik: "0001472012"
company_name: "Immunome Inc."
filed_at: "2023-11-08T23:59:59+00:00"
generated_at: "2026-06-08T09:11:11.785303+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Immunome appoints Jean-Jacques Bienaimé as Class II director; initial option grant of $270K

## Summary
- Jean-Jacques Bienaimé appointed as Class II director effective Nov 7, 2023, term through 2025 annual meeting.
- Appointed to Audit, Compensation, and Nominating & Corporate Governance Committees.
- Receives annual cash retainers totaling $57,500 ($40K board, $7.5K audit, $5K each for comp and nominating).
- Granted initial option with Black-Scholes value of $270K vesting quarterly over three years.
- Eligible for automatic annual option grants of $135K at each annual meeting, vesting over 12 months.

## SEC filing metadata
- accession: 0001104659-23-115534
- form_type: 8-K
- ticker: IMNM
- cik: 0001472012
- company_name: Immunome Inc.
- filed_at: 2023-11-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472012/000110465923115534/0001104659-23-115534-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472012/000110465923115534/tm2330142d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-115534
- JSON: https://secwatch.observer/filing/0001104659-23-115534.json
- Plain text: https://secwatch.observer/filing/0001104659-23-115534.txt

## Key facts
- Executive change
  Jean-Jacques Bienaimé was appointed as Class II Director at Immunome Inc..
  - Action: appointed
  - Role: Class II Director
  source text: appointed Jean-Jacques Bienaimé as a Class II director of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1472012/000110465923115534/0001104659-23-115534-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.